Can At-Home DNA Tests Detect Huntington's Disease?
At a Glance
No, at-home DNA tests cannot detect Huntington’s disease. Consumer genetic tests lack the technology to count the complex CAG repeat mutations that cause the condition. Testing requires specialized clinical labs and should only be done with the guidance of a genetic counselor.
No, at-home DNA tests like 23andMe cannot detect Huntington’s disease, and they should never be used to try to diagnose it. Direct-to-consumer (DTC) genetic testing companies do not have the technical capability to accurately test for the specific genetic mutation that causes Huntington’s disease [1]. In fact, standard health reports from these companies do not even attempt to test for it. Furthermore, testing for Huntington’s disease involves profound psychological risks, and medical guidelines strongly emphasize that testing must only be done with the guidance and support of a genetic counselor and a specialized medical team [2][3].
The Technical Limitations of At-Home DNA Tests
Huntington’s disease is caused by a specific type of genetic mutation in the HTT gene called a CAG repeat expansion. In a person with Huntington’s disease, a sequence of DNA building blocks (Cytosine, Adenine, Guanine, or CAG) repeats itself too many times [4].
At-home DNA testing companies typically use a technology called SNP microarrays [5]. This technology is designed to look at single, isolated letters in your DNA code to find common variations [6]. It is technically incapable of “counting” long strings of repetitive DNA like the CAG repeats that cause Huntington’s [1].
Because of this limitation, standard DTC tests simply omit Huntington’s disease entirely. This can lead to false reassurance if someone assumes a “clear” health report means they are free of the disease. Conversely, some people download their “raw DNA data” from these companies and upload it to third-party analysis websites. Because the original microarray data is fundamentally unsuited for counting CAG repeats, this practice frequently generates terrifying false positives. Across all health conditions, research has shown that approximately 40% of positive health-related findings from direct-to-consumer tests are incorrect when compared to clinical-grade testing [7], and the risk of error is particularly high for repeat expansion disorders.
To accurately diagnose Huntington’s disease, specialized clinical laboratories use advanced techniques, such as PCR-based fragment analysis or Southern blot hybridization, which can exactly count the number of CAG repeats [1]. Without an exact count, it is impossible to determine if a person will develop the disease. Relying on at-home test data for this kind of information can lead to severe misinterpretation, false reassurance, or unnecessary panic [8][9].
The Missing Safety Net: Genetic Counseling and Psychological Support
Even if an at-home test could accurately count CAG repeats, medical professionals strongly advise against using them because they completely bypass the critical safety framework required for Huntington’s disease testing.
While there are treatments to help manage the symptoms of Huntington’s disease [10], there is currently no cure that can stop or slow its progression. Because of this, learning that you carry the gene has life-altering psychological implications. Studies show that predictive genetic testing for Huntington’s disease is uniquely associated with significant increases in distress and anxiety compared to testing for many other conditions [11][12].
Due to these profound emotional risks, the established standard of care for predictive Huntington’s disease testing requires an integrated, multidisciplinary approach [2]. This process involves:
- Pre-test genetic counseling: To ensure you fully understand the medical, emotional, and financial implications of taking the test before you commit to it [4]. For example, in the United States, the Genetic Information Nondiscrimination Act (GINA) protects against health insurance and employment discrimination, but it does not protect you from being denied life, disability, or long-term care insurance.
- Psychological evaluation: To assess your current mental health, coping strategies, and support systems [13].
- Post-test support: Receiving the results in person alongside a neurologist and psychologist who can help you process the information, provide immediate emotional support, and begin assembling a long-term symptom management and care plan [10].
Direct-to-consumer testing delivers complex, life-altering results to a screen or an inbox without any of this necessary human support. It leaves individuals to interpret the results and manage the emotional fallout entirely on their own, which can be devastating [14]. Furthermore, your genetic results inherently reveal information about your biological family members. Comprehensive genetic counseling helps you navigate the ethical and interpersonal challenges of whether and how to share this information with your family [15][16].
The Right Way to Get Tested
If you have a family history of Huntington’s disease and are considering predictive testing, the safest and most accurate path is through a specialized medical clinic. You can start by asking your primary care doctor for a referral to a genetic counselor who specializes in neurogenetics, or by contacting a Huntington’s Disease Society of America (HDSA) Center of Excellence. These professionals will ensure you get accurate, clinical-grade testing while providing the psychological support you deserve.
Common questions in this guide
Can I use 23andMe or other at-home tests to check for Huntington's disease?
Why do third-party DNA analysis sites give false positives for Huntington's disease?
How is genetic testing for Huntington's disease officially done?
Why is a genetic counselor required for Huntington's disease testing?
Can a genetic test for Huntington's disease affect my life insurance?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is the clinical process for getting tested for Huntington's disease, and who would be on my care team?
- 2.Can you refer me to a genetic counselor who specializes in neurodegenerative diseases like Huntington's?
- 3.How long does the genetic counseling process typically take before I can actually proceed with testing?
- 4.What are the potential implications of a positive test result for my life insurance, and when should I address that?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (16)
- 1
Huntington Disease: Molecular Diagnostics Approach.
Bastepe M, Xin W
Current protocols in human genetics 2015; (87()):9.26.1-9.26.23 doi:10.1002/0471142905.hg0926s87.
PMID: 26439718 - 2
1993-2014: two decades of predictive testing for Huntington's disease at the Medical Genetics Unit of the University of Genoa.
Mandich P, Lamp M, Gotta F, et al.
Molecular genetics & genomic medicine 2017; (5(5)):473-480 doi:10.1002/mgg3.238.
PMID: 28944231 - 3
Genetic counseling and testing for Huntington's disease: A historical review.
Nance MA
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2017; (174(1)):75-92 doi:10.1002/ajmg.b.32453.
PMID: 27174011 - 4
Genetic testing for Huntington's disease: Past, present and future. How could genetic data be used to improve clinical practice?
Hensman Moss DJ, Ireland R, Chapman G, et al.
Journal of Huntington's disease 2025; 18796397251391953 doi:10.1177/18796397251391953.
PMID: 41432663 - 5
Single-nucleotide polymorphism-based chromosomal microarray analysis provides clues and insights into disease mechanisms.
Daum H, Meiner V, Hacohen N, et al.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2019; (54(5)):655-660 doi:10.1002/uog.20230.
PMID: 30693591 - 6
[Prenatal diagnosis of a Pallister-Killian syndrome case through analysis of a supernumerary chromosome using single nucleotide polymorphism array].
Li S, Shen H, Jin Y, et al.
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2016; (33(5)):682-5 doi:10.3760/cma.j.issn.1003-9406.2016.05.023.
PMID: 27577223 - 7
Addressing the accuracy of direct-to-consumer genetic testing.
Wu S, Pollard J, Chowdry A, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2019; (21(3)):758-759 doi:10.1038/s41436-018-0094-5.
PMID: 29955106 - 8
Direct-to-Consumer Tests on the Market Today: Identifying Valuable Tests from Those with Limited Utility.
Isbell TS
Clinics in laboratory medicine 2020; (40(1)):13-23 doi:10.1016/j.cll.2019.11.008.
PMID: 32008636 - 9
Genetic testing for Alzheimer's disease: trends, challenges and ethical considerations.
Rentería ME, Mitchell BL, de Lara AM
Current opinion in psychiatry 2020; (33(2)):136-140 doi:10.1097/YCO.0000000000000573.
PMID: 31770136 - 10
Unraveling Huntington's Disease: A Report on Genetic Testing, Clinical Presentation, and Disease Progression.
Ahmed M, Mridha D
Cureus 2023; (15(8)):e43377 doi:10.7759/cureus.43377.
PMID: 37700984 - 11
A Systematic Review of the Psychological Implications of Genetic Testing: A Comparative Analysis Among Cardiovascular, Neurodegenerative and Cancer Diseases.
Oliveri S, Ferrari F, Manfrinati A, Pravettoni G
Frontiers in genetics 2018; (9()):624 doi:10.3389/fgene.2018.00624.
PMID: 30619456 - 12
BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer.
Nilsson MP, Törngren T, Henriksson K, et al.
Breast cancer research and treatment 2018; (168(1)):117-126 doi:10.1007/s10549-017-4584-y.
PMID: 29164420 - 13
Guidelines for presymptomatic testing for Huntington's disease: past, present and future in France.
Clément S, Gargiulo M, Feingold J, Durr A
Revue neurologique 2015; (171(6-7)):572-80.
PMID: 26002494 - 14
Ethical and Psychosocial Issues Associated with Genetic Testing for Hereditary Tumor Predisposition Syndromes.
Hachmeriyan M, Levkova M, Yahya D, et al.
Healthcare (Basel, Switzerland) 2025; (13(8)) doi:10.3390/healthcare13080880.
PMID: 40281828 - 15
Psychosocial Impact of Huntington's Disease and Incentives to Improve Care for Affected Families in the Underserved Region of the Slovak Republic.
Hubčíková K, Rakús T, Mühlbäck A, et al.
Journal of personalized medicine 2022; (12(12)) doi:10.3390/jpm12121941.
PMID: 36556162 - 16
Predicting age of onset and progression of disease in late-onset genetic neurodegenerative diseases: An ethics review and research agenda.
Rensink M, Bolt I, Schermer M
European journal of human genetics : EJHG 2024; (32(11)):1361-1370 doi:10.1038/s41431-024-01688-7.
PMID: 39317749
This page is for informational purposes only and does not replace professional medical advice. Always consult a genetic counselor or neurologist regarding predictive testing for Huntington's disease.
Get notified when new evidence is published on Huntington disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.